C12R 1 - Micro-organisms - Patents Sitemap

Patents for C12R 1 - Micro-organisms (92,025)
11/1986
11/12/1986	EP0201416A1 Particles having immunogen HBs antigen properties and bearing an antigenic site, foreign to the epitopes of HBs antigen, vectors and animal cells for the production of those particles of mixed vaccines
11/12/1986	EP0201239A1 Process for the isolation of fermentation products
11/12/1986	EP0201208A1 Supersecreting mutants of saccharomyces cerevisiae
11/12/1986	EP0201187A1 Determination of glycated (glycosylated) hemoglobin in blood
11/12/1986	EP0201086A2 Method of producing useful high-molecular-weight substances by culturing proliferous animal cells and culture system therefor
11/12/1986	EP0201039A2 L-aminoacylases
11/12/1986	EP0200986A1 Recombinant human interleukin-1
11/12/1986	EP0200909A2 Preparation of protein G and/or fragments thereof
11/12/1986	CN86102773A Method for producing l-sorbose
11/12/1986	CN85103674A Hyaluronic acid from bacterial culture
11/11/1986	US4622301 2-Oxocarboxylic acid reductase and its preparation
11/07/1986	EP0108787A4 The manufacture and expression of structural genes.
11/06/1986	WO1986006494A2 Means for in vitro diagnostic of malignant cells originating from the digestive tube
11/06/1986	WO1986006409A1 High level amplification and expression of exogenous dna
11/06/1986	WO1986006408A1 HIGH YIElD PRODUCTION OF ACTIVE FACTOR IX
11/06/1986	WO1986006407A1 IDENTIFICATION OF AN IgE-BINDING PROTEIN BY MOLECULAR CLONING
11/06/1986	WO1986006406A1 Vectors for the expression and secretion of hirudin by transformed yeasts
11/06/1986	WO1986004217A3 Protein hydrolysates, production process and drugs containing th em
11/05/1986	EP0200655A1 Expression and secretion vectors for hirudine by way of transformed yeasts
11/05/1986	EP0200653A1 Hybrid cells producing a hepatitis B virus antigen obtained from hepatocytes and established monkey cells, process for the obtention of these hybrid cells and use thereof in the production of this antigen
11/05/1986	EP0200565A2 Method for production of peroxidase
11/05/1986	EP0200464A2 A tumor associated antigen
11/05/1986	EP0200425A2 Recombinant DNA expression vectors and DNA compounds
11/05/1986	EP0200421A2 Expression of factor VII activity in mammalian cells
11/05/1986	EP0200344A2 Microorganisms as pesticides
11/05/1986	EP0200280A2 Oxidation resistant IL-2 muteins and their production, formulations containing such muteins, and DNA sequences and expression vectors coding for such muteins and corresponding transformed host cells
11/05/1986	EP0200231A2 Methods for preparing rabbit monoclonal antibodies, the cell lines used therein and the antibodies produced thereby
11/05/1986	EP0200069A2 Continuous process for the enzymatic preparation of isomaltulose
11/05/1986	EP0199972A1 3-Hydroxy-dicarboxylic acids and process for their preparation
11/05/1986	EP0199943A2 Process for producing D-alpha-amino acids
11/05/1986	EP0199769A1 Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
11/05/1986	EP0199756A1 Monoclonal antibodies and their use
11/05/1986	EP0199755A1 Monoclonal antibodies and their use
11/05/1986	EP0199754A1 Monoclonal antibodies and their use
11/05/1986	EP0093436B1 Process for preparing permanent animal and human cell lines, and their use
11/05/1986	CN86102090A Procedure for obtaining, dna, rna, peptides, polypeptides, or proteins by recombinant dna techemiques
11/04/1986	US4621061 Plasmid p SG 2 and process for its preparation
11/04/1986	US4621057 N-acetylhexosamine oxidase and process for producing the same
11/04/1986	US4621052 Process for the production of human epidermal growth factor
11/04/1986	US4621051 Process for the production of human multiplication-stimulating activity
11/04/1986	CA1213546A1 Chimeramycins
11/04/1986	CA1213542A1 Antitumor antibiotics bbm-2040 produced by streptomyces
11/04/1986	CA1213537A1 Polypeptide expression method
11/04/1986	CA1213536A1 Monoclonal antibody, method of producing the same and use thereof
10/1986
10/29/1986	EP0199698A2 Process for the extraction and purification of proteins from culture media producing them
10/29/1986	EP0199591A2 Valiolamine derivatives and production thereof
10/29/1986	EP0199586A2 Tumour-associated antigen
10/29/1986	EP0199574A2 Human tissue plasminogen activator mutants, methods and intermediates therefor, and compositions using such mutants
10/29/1986	EP0199548A2 Method for producing L-sorbose
10/29/1986	EP0199535A2 Lactobacillus acidophilus strains of bacteria and compositions thereof
10/29/1986	EP0199301A1 Recombinant acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS
10/29/1986	EP0199196A2 Monoclonal antibody and method for the production thereof
10/29/1986	EP0199141A2 Monoclonal antibodies to human gastrointestinal cancer
10/29/1986	EP0199105A1 Alcohol-free beverages on the base of cereals, process and microorganisms for their production
10/29/1986	EP0199091A1 Process for the production of a herpes simplex virus type 2 specific antigen, suitable agents therefor and the use of this antigen
10/29/1986	EP0199018A2 Expression in e.coli of hybrid polypeptides containing the growth hormone releasing factor sequence
10/29/1986	EP0198866A1 Monoclonal antibodies and their use
10/28/1986	CA1213235A1 Process for preparing high dextrose starch hydrolysates from immobilized glucoamylase
10/28/1986	CA1213232A1 Process for the purification of the dextrane-saccharase
10/28/1986	CA1213229A1 Antibodies having dual specificities, their preparation and uses therefor
10/28/1986	CA1213228A1 Agricultural-chemical-producing endosymbiotic bacteria and method of preparing and using same
10/23/1986	WO1986006171A1 Test for rheumatic fever and monoclonal antibodies useful therefor
10/23/1986	WO1986006101A1 Novel procoagulant proteins
10/23/1986	WO1986006100A1 Human anti-inflammatory phospholipase inhibitor protein
10/23/1986	WO1986006099A1 EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
10/23/1986	WO1986006096A1 Von willebrand factor
10/23/1986	WO1986006079A1 Purified protein having angiogenic activity and methods of preparation
10/23/1986	WO1986006077A1 A method and a hybrid promoter for controlling exogenous gene transcription
10/23/1986	WO1986006076A1 Recombinant inhibin
10/22/1986	EP0198474A1 Hepatitis B surface antigen formed by recombinant DNA techniques, vaccines, diagnostics, cell lines and methods of forming same
10/22/1986	EP0198415A2 Alteration of the DNA sequence between the Shine-Dalgarno sequence and the start codon of the trp operon to increase the expression of proteins
10/22/1986	EP0198387A2 7-Hydroxyguanine compounds, process for preparing said compounds, pharmaceutical composition, and use thereof
10/22/1986	EP0198328A2 Vaccinia DNA
10/22/1986	EP0198039A1 $i(AOTUS) INTERSPECIES HYBRIDOMAS AND MONOCLONAL RECEPTORS PRODUCED THEREBY
10/22/1986	EP0198014A1 Vectors containing a gene for a protein having erythroid-potentiating activity and recombinant dna methods for producing said protein
10/22/1986	EP0197974A1 Acino-foetal differentiation proteins associated to the pancreas cancer, antiserum and monoclonal antibodies to said proteins, preparation methods
10/22/1986	EP0197969A1 Process for the preparation of cellulose film, cellulose film produced thereby, artificial skin graft and its use.
10/21/1986	US4618602 Glucosidase inhibitors
10/21/1986	US4618582 Process for producing Xanthomonas biopolymers
10/21/1986	US4618581 Aerobic fermentation of claviceps fusiformis
10/21/1986	US4618579 High yields of glucose obtained by hydrolysis of insoluble low-solids starch slurry residue
10/21/1986	US4618493 Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them
10/21/1986	CA1212915A1 Process for the preparation of hybrid human leukocyte interferons
10/15/1986	EP0197797A2 Improved recombinant hosts, their production and use
10/15/1986	EP0197748A2 Magnetic alteration of cellulose during its biosynthesis
10/15/1986	EP0197497A2 Novel baker's yeast and process for making bread
10/15/1986	EP0197484A2 Method for producing optically active glycol derivatives
10/15/1986	EP0197435A2 Choriocarcinoma monoclonal antibodies and antibody panels
10/15/1986	EP0197360A1 Use of efomycines for increasing the efficiency by animals, efomycines and their preparation
10/15/1986	EP0197335A1 Process for producing L-lysine
10/15/1986	EP0197149A1 Method of obtaining human leukocytic interferon
10/15/1986	CN86101798A Process for the extraction and purification of proteins from culture media producing them
10/14/1986	US4617378 Purification of biologically active human immune interferon
10/14/1986	US4617273 Bacillus cultivation
10/14/1986	US4617269 Process for the preparation of fructosyl disaccharides
10/14/1986	US4617267 Genetic engineering
10/14/1986	CA1212645A1 Hyaluronic acid from bacterial culture
10/14/1986	CA1212644A1 Process and medium for culturing ant venom gland cells
10/14/1986	CA1212643A1 Mutation assays involving blood cells that metabolize toxic substances
10/14/1986	CA1212642A1 Process for producing proteins correlated with the diphtheric toxin

1 ... 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 ... 921